Zynex Medical has been a leading provider of relief for patients with functional disability through the creation, distribution and marketing of electrotherapy products. Utilizing various methods of non-invasive muscle stimulation and state-of-the-art electromyography technology, Interferential Current (IFC) and Transcutaneous Electrical Nerve Stimulation (TENS), Zynex Medical offers patients a new lease on life by increasing mobility and providing independence.

Zynex Medical also has a product for stroke victims, called NeuroMove, it is designed to increase functionality among stroke victims by teaching the healthy parts of the brain to compensate for the injured areas. NeuroMove(TM) monitors muscle activity and selects signals from the brain indicating that the patient is attempting to move a certain muscle. It then allows the particular muscle to move through electrical stimulation. Many times, the connection between the brain and muscle is restored.

The techniques offered by the company are relatively new for some applications, like fibromyalgia,

...

By William Patalon III Executive Editor Money Morning/The Money Map Report The U.S. Federal Reserve will be in the spotlight again this week - and not because of those speaking engagements that seem to help whipsaw investor emotions. Tomorrow (Tuesday) and Wednesday, central bank Chairman Ben S. Bernanke will meet with his fellow policymakers on the interest-rate setting Federal Open Market Committee (FOMC). After one of the most aggressive rate-cutting campaigns in its history - a stretch that’s seen the Fed pare its benchmark Federal Funds rate from 5.25% in mid-September all the way down to 2.0% today - most experts believe the central bank’s next move will be to take interest rates higher to blunt inflation. But few of these Fed-watchers are willing to predict that the increase will be made now, or even in August, although the interest-rate-futures market is ...

In last week’s strategy article I did some basic analysis on the MACD; a trend indicator. In this week’s article I took a look at stochastics; a momentum indicator. However, unlike the traditional overbought/oversold triggers associated with using stochastics I have opted to use a cross of the mid-line (50) with a base fast stochastic setting of [39,1,1]. I couldn’t test for the optimum [39,1,3] using the %K smooth as a trade trigger, so the generated signals were not as good as the basic slow stochastic signal I normally use (see chart for differences in the quality of the signals), but it did give an indication of the efficacy of this strategy.

Test period: A complete bull-bear cycle defined by the S&P …

I'm sliding under the table to you some excerpts from a recent interview that our Director of Trader Education, Jamie Hodge, gave to our good friend Dave Mabe of StockTickr. You'll understand after reading the entire interview how to win against today's market that's eliminated many of the information advantages traders used to have and how to trade where the greatest odds of winning exist - below is a slice of the interview.Reprinted with permission:

Q: What single lesson did you learn along the way that has helped you the most in your trading?Never become complacent – especially when you’ve been "gimmick trading" all of your career. I refer to any trading practice that can become extinct from a rule change or system replacement as gimmick. The prime example was SOES (Small Order Execution System). Once the SOES phenomenon started taking root, the big boys were

...